Cargando…

Durable responses with ALK inhibitors for primary refractory anaplastic lymphoma Kinase-positive large B-cell lymphoma

Detalles Bibliográficos
Autores principales: Takiar, Radhika, Phillips, Tycel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285534/
https://www.ncbi.nlm.nih.gov/pubmed/36812691
http://dx.doi.org/10.1182/bloodadvances.2022007537
_version_ 1785061628311502848
author Takiar, Radhika
Phillips, Tycel J.
author_facet Takiar, Radhika
Phillips, Tycel J.
author_sort Takiar, Radhika
collection PubMed
description
format Online
Article
Text
id pubmed-10285534
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-102855342023-06-23 Durable responses with ALK inhibitors for primary refractory anaplastic lymphoma Kinase-positive large B-cell lymphoma Takiar, Radhika Phillips, Tycel J. Blood Adv Research Letter The American Society of Hematology 2023-02-24 /pmc/articles/PMC10285534/ /pubmed/36812691 http://dx.doi.org/10.1182/bloodadvances.2022007537 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Letter
Takiar, Radhika
Phillips, Tycel J.
Durable responses with ALK inhibitors for primary refractory anaplastic lymphoma Kinase-positive large B-cell lymphoma
title Durable responses with ALK inhibitors for primary refractory anaplastic lymphoma Kinase-positive large B-cell lymphoma
title_full Durable responses with ALK inhibitors for primary refractory anaplastic lymphoma Kinase-positive large B-cell lymphoma
title_fullStr Durable responses with ALK inhibitors for primary refractory anaplastic lymphoma Kinase-positive large B-cell lymphoma
title_full_unstemmed Durable responses with ALK inhibitors for primary refractory anaplastic lymphoma Kinase-positive large B-cell lymphoma
title_short Durable responses with ALK inhibitors for primary refractory anaplastic lymphoma Kinase-positive large B-cell lymphoma
title_sort durable responses with alk inhibitors for primary refractory anaplastic lymphoma kinase-positive large b-cell lymphoma
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285534/
https://www.ncbi.nlm.nih.gov/pubmed/36812691
http://dx.doi.org/10.1182/bloodadvances.2022007537
work_keys_str_mv AT takiarradhika durableresponseswithalkinhibitorsforprimaryrefractoryanaplasticlymphomakinasepositivelargebcelllymphoma
AT phillipstycelj durableresponseswithalkinhibitorsforprimaryrefractoryanaplasticlymphomakinasepositivelargebcelllymphoma